Abstract
Our research group has dedicated efforts to the implementation of CAR T-cell therapy at the Blood Center-RP. With the support of FAPESP (NPOP project 2020/07055-9), we have made significant progress in the production of lentiviral vectors for the CAR-T cell project, for which later this year we will start the I/II clinical study approved by ANVISA. Since the inception of the NPOP project …